Semaglutide / GLP-1 agonists
Also known as: ozempic, wegovy, tirzepatide
Prescription weight and diabetes medicines; see the Pulse Metabolic & GLP-1 coverage for the evidence.
Metabolic & fat-loss agentsGLP-1 receptor agonistEvidence for performance claims:Gold· human data
Legal status: UK: prescription-only medicine — legitimately available only via a doctor's prescription. Checked 2026-07-26.
Prohibited in sport: Yes — on the WADA Prohibited List.
Approved medical use: Licensed for type-2 diabetes and, for some, weight management.
Full breakdown in progress
We hold this page to the same bar as every other: each claim verified against a primary source before it is published. This compound’s full breakdown is being reviewed and will appear here once it clears that check. The legal status and safety information above stand.